Kezar Life Sciences has become the latest biotech to decide that it could do better than a buyout offer from Concentra Biosciences. Concentra’s parent company Tang Capital Partners has a track ...

Apart from reviewing some of the top ICO cryptos currently in existence, we’ll also examine some upcoming ICOs and tackle the inherent risks and rewards of such early-stage investments.

1 Day CON -2.54% DJIA 0.37% S&P Mid Cap 400 0.15% Health Care/Life Sciences -0.15% ...

Earlier on Thursday, Kezar Life Sciences rejected the previously disclosed unsolicited, non-binding proposal from Concentra Biosciences for cash consideration of $1.10 per share, plus a contingent ...

(RTTNews) - Kezar Life Sciences (KZR) announced that its Board has rejected the unsolicited, non-binding proposal from Concentra Biosciences, to acquire all of the outstanding shares of common ...

Ethereum, Filecoin, Chainlink, and many other billion-dollar cryptocurrencies raised funds via ICO campaigns, so this investment niche can be lucrative. So, let’s get acquainted with the top ...

UK data protection regulator the Information Commissioner's Office (ICO) has launched an investigation into MoneyGram International, the world's second-largest money transfer provider, following a ...

Looking to capitalize on this momentum, Dogizen has announced the first ever Telegram-based ICO. Dogizen is now ideally placed to convert its gaming audience into a thriving investor community for ...

ADDISON, Texas--(BUSINESS WIRE)--Concentra® (NYSE: CON), the nation’s leader in occupational medicine, today announced the opening of a new medical center in Chattanooga, Tennessee. The medical ...

Concentra Group Holdings Parent, Inc. (NYSE:CON), the largest provider of occupational health services in the United States, has recently attracted attention from Wall Street analysts. The company ...

ADDISON, Texas, October 07, 2024--Concentra® (NYSE: CON), the nation’s leader in occupational medicine, today announced the opening of a new medical center in Orlando, Florida. The medical ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...